# Study of a Group B Streptococcus Vaccine in Pregnant Women Living With HIV and in Pregnant Women Who do Not Have HIV

> **NCT04596878** · PHASE2 · COMPLETED · sponsor: **Minervax ApS** · enrollment: 205 (actual)

## Conditions studied

- Group B Streptococcal Infection

## Interventions

- **BIOLOGICAL:** GBS-NN/NN2
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04596878
- **Lead sponsor:** Minervax ApS
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-19
- **Primary completion:** 2022-05-18
- **Final completion:** 2023-05-11
- **Target enrollment:** 205 (ACTUAL)
- **Last updated:** 2023-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04596878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04596878, "Study of a Group B Streptococcus Vaccine in Pregnant Women Living With HIV and in Pregnant Women Who do Not Have HIV". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04596878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*